Patent Assignment
Reel/Frame 070239/0739
Security Interest
Recorded: 2025-02-17
Pages: 11
Assignor
REVANCE THERAPEUTICS, INC.
Executed: 2025-02-06
Assignee
JPMORGAN CHASE BANK, N.A.
3424 PEACHTREE ROAD NE, FLOOR 21, ATLANTA, GEORGIA, 30326
Covered Properties
(53)
Injectable Botulinum Toxin Formulations
Application:
17/951,220 →
Publication:
US US20240058628A1
Albumin-Free Botulinum Toxin Formulations
Application:
18/414,311 →
Publication:
US US20240382571A1
Methods and Kits for Topical Application, Removal, and Inactivation of Therapeutic or Cosmetic Toxin Compositions
Application:
17/114,486 →
Publication:
US US20210189326A1
Methods and Compositions for Treating Skin Conditions Associated With Vascular Hyper-reactivity
Application:
16/984,036 →
Publication:
US US20220347275A1
Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect
Application:
17/472,525 →
Publication:
US US20220062400A1
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
17/135,938 →
Publication:
US US20210252116A1
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
17/234,690 →
Publication:
US US20210308236A1
Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s)
Application:
18/359,633 →
Publication:
US US20240000906A1
Methods of Treating Cervical Dystonia in a Subject Having Underlying Condition(s)
Application:
18/455,179 →
Publication:
US US20230390368A1
Methods of Treating a Spastic Disorder in a Subject Having Underlying Condition(s)
Application:
18/540,403 →
Publication:
US US20240108700A1
Methods of Treating an Optic Disease in a Subject
Application:
18/521,777 →
Publication:
US US20240100135A1
Transmucosal Botulinum Toxin Compositions, Kits, and Methods for Treating Bladder Disorders
Application:
18/973,057 →
Publication:
US US20250332232A1
Methods of Treatment for Cervical Dystonia
Injectable Botulinum Toxin Formulations and Methods of Use Thereof Having High Response Rate and Long Effect Duration
Application:
18/595,365 →
Publication:
US US20250064905A1
Injectable Botulinum Toxin Methods for Treating Headaches
Application:
17/912,513 →
Publication:
US US20230210963A1
Injectable Botulinum Toxin Methods for Treating Headaches
Application:
18/244,279 →
Publication:
US 2024/0216486
Methods for Treating Cervical Dystonia
Application:
18/031,861 →
Publication:
US US20240269246A1
Methods of and Compositions for Treatment of Upper Limb Spasticity
Application:
18/278,169 →
Publication:
US US20250268996A1
Arginine Heteromers for Topical Administration
Arginine Heteromers for Topical Administration
Compositions and Methods for Treating Acne
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Methods for Treating Pain by Topical Application and Transdermal Delivery of Botulinum Toxin
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Compositions and Methods for Topical Diagnostic and Therapeutic Transport
Compositions and methods for topical application and transdermal delivery of botulinum toxins
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Injectable Botulinum Toxin Formulations
Injectable Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin
Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin
Antimicrobial Peptide, Compositions, and Methods of Use
Compositions and Methods for Safe Treatment of Rhinitis
Composition for Therapeutic and Cosmetic Botulinum Toxin
Pharmaceutical Botulinum Toxin Compositions
Compositions, Methods and Devices for Preparing Less Painful Botulinum Toxin Formulations
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
Transmucosal Botulinum Toxin Compositions, Kits, and Methods for Treating Bladder Disorders
Methods of Using Botulinum Toxin for the Treatment of Hypervolemic Lip Deformity (Lip Ectropion)
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2006
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018628/0284 →
Assignment of Assignor's Interest
Jan 17, 2007
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018768/0065 →
Assignment of Assignor's Interest
Oct 6, 2008
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC
Reel/Frame 021639/0144 →
Assignment of Assignor's Interest
Oct 7, 2008
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 021662/0548 →
Assignment of Assignor's Interest
Oct 7, 2008
From: WAUGH, JACOB M.; LEE, JAE HOON
To: REVANCE THERAPEUTICS, INC
Reel/Frame 021662/0606 →
Security Agreement
May 29, 2009
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 022756/0549 →
Security Agreement
May 24, 2010
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 024432/0187 →
Security Agreement
Sep 22, 2011
From: REVANCE THERAPEUTICS, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 026953/0726 →
Release of Security Interest Recorded at Reel/Frame 24432/321, 24432/284, 24432/317, 22432/187, and 22756/549
Oct 4, 2011
From: LEADER VENTURES, LLC
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 027015/0658 →
Release of Security Interest
Sep 27, 2019
From: HERCULES CAPITAL, INC. (F/K/A HERCULES TECHNOLOGY GROWTH CAPITAL, INC.)
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 050565/0300 →
Assignment of Assignor's Interest
Mar 16, 2022
From: RUEGG, CURTIS L.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059281/0037 →
Change of Name
Mar 17, 2022
From: ESSENTIA BIOSYSTEMS, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059435/0371 →
Employee Proprietary Information and Inventions Agreement
Mar 17, 2022
From: WAUGH, JACOB
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 059435/0362 →
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Assignment of Assignor's Interest
Mar 18, 2022
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059436/0236 →
Assignment of Assignor's Interest
Mar 18, 2022
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 059440/0061 →
Assignment of Assignor's Interest
Jul 5, 2022
From: RUEGG, CURTIS L.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 060399/0215 →
Assignment of Assignor's Interest
Apr 17, 2023
From: RUBIO, ROMAN; NGUYEN-CLEARY, THAI; OH, CHAD
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 063350/0858 →
Assignment of Assignor's Interest
Jul 27, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 064401/0001 →
Assignment of Assignor's Interest
Jul 27, 2023
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 064401/0300 →
Assignment of Assignor's Interest
Aug 24, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 064712/0088 →
Assignment of Assignor's Interest
Aug 24, 2023
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 064712/0721 →
Assignment of Assignor's Interest
Oct 23, 2023
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 065317/0816 →
Assignment of Assignor's Interest
Oct 23, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 065317/0047 →
Assignment of Assignor's Interest
Nov 29, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 065708/0926 →